Search
Supernus Pharmaceuticals Inc
SUPNAdd to Watchlist
44.380USD
+0.800+1.84%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.53BMarket Cap
LossP/E TTM
Supernus Pharmaceuticals Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Supernus Pharmaceuticals Inc is 9.20, ranking 40 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -86.86, which is -1778.09% below the recent high of 1457.52 and -81.66% above the recent low of -157.78.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
